Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EBITDA (2017 - 2025)

Historic EBITDA for MedWellAI (MWAI) over the last 11 years, with Q3 2025 value amounting to -$317727.0.

  • MedWellAI's EBITDA rose 4579.81% to -$317727.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year decrease of 3700.35%. This contributed to the annual value of -$2.8 million for FY2025, which is 6903.6% up from last year.
  • According to the latest figures from Q3 2025, MedWellAI's EBITDA is -$317727.0, which was up 4579.81% from -$1.0 million recorded in Q2 2025.
  • MedWellAI's 5-year EBITDA high stood at $1.0 million for Q1 2024, and its period low was -$22.1 million during Q2 2023.
  • Moreover, its 5-year median value for EBITDA was -$610649.0 (2022), whereas its average is -$3.1 million.
  • Per our database at Business Quant, MedWellAI's EBITDA plummeted by 474728.17% in 2021 and then surged by 50501.84% in 2024.
  • Quarter analysis of 5 years shows MedWellAI's EBITDA stood at -$331865.0 in 2021, then crashed by 84.01% to -$610649.0 in 2022, then skyrocketed by 45.03% to -$335679.0 in 2023, then tumbled by 113.5% to -$716662.0 in 2024, then surged by 55.67% to -$317727.0 in 2025.
  • Its last three reported values are -$317727.0 in Q3 2025, -$1.0 million for Q2 2025, and -$804630.0 during Q1 2025.